BR9710250A - Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina - Google Patents
Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicinaInfo
- Publication number
- BR9710250A BR9710250A BR9710250A BR9710250A BR9710250A BR 9710250 A BR9710250 A BR 9710250A BR 9710250 A BR9710250 A BR 9710250A BR 9710250 A BR9710250 A BR 9710250A BR 9710250 A BR9710250 A BR 9710250A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- bromothiacumycin
- patient
- treating
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/678,906 US5767096A (en) | 1996-07-12 | 1996-07-12 | Bromotiacumicin compounds |
PCT/US1997/011064 WO1998002447A1 (en) | 1996-07-12 | 1997-06-24 | Bromotiacumicin compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9710250A true BR9710250A (pt) | 1999-08-10 |
Family
ID=24724791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9710250A BR9710250A (pt) | 1996-07-12 | 1997-06-24 | Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina |
Country Status (20)
Country | Link |
---|---|
US (1) | US5767096A (pt) |
EP (1) | EP0923594B1 (pt) |
JP (1) | JP2000515512A (pt) |
KR (1) | KR100476799B1 (pt) |
CN (1) | CN1149220C (pt) |
AR (1) | AR007854A1 (pt) |
AT (1) | ATE225364T1 (pt) |
AU (1) | AU730839B2 (pt) |
BR (1) | BR9710250A (pt) |
CA (1) | CA2257984A1 (pt) |
CZ (1) | CZ294843B6 (pt) |
DE (1) | DE69716094T2 (pt) |
DK (1) | DK0923594T3 (pt) |
ES (1) | ES2186900T3 (pt) |
HU (1) | HU224966B1 (pt) |
IL (1) | IL127540A (pt) |
NZ (1) | NZ333258A (pt) |
PT (1) | PT923594E (pt) |
WO (1) | WO1998002447A1 (pt) |
ZA (1) | ZA975861B (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070105791A1 (en) * | 2002-07-29 | 2007-05-10 | Optimer Pharmaceuticals, Inc. | Method of treating clostridium difficile-associated diarrhea |
ES2527052T3 (es) * | 2002-07-29 | 2015-01-20 | Optimer Pharmaceuticals, Inc. | Producción de tiacumicina |
US7906489B2 (en) * | 2004-05-14 | 2011-03-15 | Optimer Pharmaceuticals, Inc. | 18-membered macrocycles and analogs thereof |
ES2713954T3 (es) * | 2004-05-14 | 2019-05-24 | Merck Sharp & Dohme | Tratamiento de enfermedades asociadas al uso de antibióticos |
MX2007009196A (es) * | 2005-01-31 | 2009-02-25 | Optimer Pharmaceuticals Inc | Compuestos macrocilicos de 18 miembros y analogos de los mismos. |
US7378508B2 (en) * | 2007-01-22 | 2008-05-27 | Optimer Pharmaceuticals, Inc. | Polymorphic crystalline forms of tiacumicin B |
TWI523654B (zh) | 2007-11-27 | 2016-03-01 | 默沙東藥廠 | 抗生素巨環化合物以及其製造及使用之方法 |
CN102115757B (zh) * | 2010-12-14 | 2015-10-28 | 中国科学院南海海洋研究所 | 台勾霉素的生物合成基因簇及其应用 |
JO3464B1 (ar) | 2013-01-15 | 2020-07-05 | Astellas Pharma Europe Ltd | التركيبات الخاصة بمركبات التياكوميسين |
IN2013MU00711A (pt) * | 2013-03-08 | 2015-06-26 | Cipla Ltd | |
DK3139932T3 (en) | 2014-05-09 | 2018-11-12 | Astellas Pharma Europe Ltd | The treatment regimen for thiacumicin compound |
EP3316892B1 (en) | 2015-07-03 | 2023-07-19 | Tillotts Pharma AG | Novel dosage regimen of tiacumicin compound |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4918174A (en) * | 1986-09-26 | 1990-04-17 | Abbott Laboratories | Tiacumicin compounds |
-
1996
- 1996-07-12 US US08/678,906 patent/US5767096A/en not_active Expired - Lifetime
-
1997
- 1997-06-24 CZ CZ199928A patent/CZ294843B6/cs not_active IP Right Cessation
- 1997-06-24 AT AT97931411T patent/ATE225364T1/de active
- 1997-06-24 WO PCT/US1997/011064 patent/WO1998002447A1/en active IP Right Grant
- 1997-06-24 KR KR10-1999-7000117A patent/KR100476799B1/ko not_active IP Right Cessation
- 1997-06-24 EP EP97931411A patent/EP0923594B1/en not_active Expired - Lifetime
- 1997-06-24 PT PT97931411T patent/PT923594E/pt unknown
- 1997-06-24 IL IL12754097A patent/IL127540A/en not_active IP Right Cessation
- 1997-06-24 DK DK97931411T patent/DK0923594T3/da active
- 1997-06-24 ES ES97931411T patent/ES2186900T3/es not_active Expired - Lifetime
- 1997-06-24 HU HU9903902A patent/HU224966B1/hu unknown
- 1997-06-24 CA CA002257984A patent/CA2257984A1/en not_active Abandoned
- 1997-06-24 DE DE69716094T patent/DE69716094T2/de not_active Expired - Lifetime
- 1997-06-24 JP JP10506036A patent/JP2000515512A/ja active Pending
- 1997-06-24 BR BR9710250A patent/BR9710250A/pt not_active Application Discontinuation
- 1997-06-24 NZ NZ333258A patent/NZ333258A/xx not_active IP Right Cessation
- 1997-06-24 AU AU35046/97A patent/AU730839B2/en not_active Expired
- 1997-06-24 CN CNB971962537A patent/CN1149220C/zh not_active Expired - Lifetime
- 1997-07-01 ZA ZA9705861A patent/ZA975861B/xx unknown
- 1997-07-11 AR ARP970103100A patent/AR007854A1/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
HUP9903902A2 (hu) | 2001-05-28 |
DE69716094D1 (de) | 2002-11-07 |
IL127540A (en) | 2004-05-12 |
KR20000023662A (ko) | 2000-04-25 |
CA2257984A1 (en) | 1998-01-22 |
WO1998002447A1 (en) | 1998-01-22 |
CZ294843B6 (cs) | 2005-03-16 |
EP0923594B1 (en) | 2002-10-02 |
JP2000515512A (ja) | 2000-11-21 |
CN1149220C (zh) | 2004-05-12 |
AU730839B2 (en) | 2001-03-15 |
DK0923594T3 (da) | 2003-02-10 |
CZ2899A3 (cs) | 1999-03-17 |
EP0923594A1 (en) | 1999-06-23 |
HUP9903902A3 (en) | 2001-06-28 |
IL127540A0 (en) | 1999-10-28 |
NZ333258A (en) | 2000-07-28 |
KR100476799B1 (ko) | 2005-03-16 |
PT923594E (pt) | 2003-02-28 |
ATE225364T1 (de) | 2002-10-15 |
CN1225096A (zh) | 1999-08-04 |
HU224966B1 (en) | 2006-04-28 |
DE69716094T2 (de) | 2003-06-05 |
US5767096A (en) | 1998-06-16 |
AR007854A1 (es) | 1999-11-24 |
AU3504697A (en) | 1998-02-09 |
ES2186900T3 (es) | 2003-05-16 |
ZA975861B (en) | 1998-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9407799A (pt) | Composição de matéria método de tratamento e composição farmaceutica | |
BR9602542A (pt) | Composto método para o tratamento de uma doença dependente da fosforilase de glicogénio composição farmacéutica e processo para a preparação de um composto | |
BR9503812A (pt) | Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto | |
DE59710183D1 (de) | Topische mittel zur prophylaxe oder behandlung bakterieller hautinfektionen | |
PL344535A1 (en) | Use of organophosphoric compounds for the therapeutic and preventative treatment of infections | |
CA2189658A1 (en) | Controlled-Release Dosage Forms of Azithromycin | |
TJ270B (en) | 5,6-Dichlorobenzimidazole derivatives process for their preparation pharmaceutical composition and method of treatment or prophylaxis of virus infections | |
EP0758242A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CYTOMEGALOVIRUS (CMV) INFECTIONS | |
EE9800234A (et) | Ravimeetod ja farmatseutiline kompositsioon | |
AU6411199A (en) | Angiogenically effective unit dose of fgf and method of administering | |
BR9710250A (pt) | Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina | |
HUP0101901A3 (en) | Pharmaceutical composition for combined therapeutic treatment of refractory depression and combined treating process | |
AU3681095A (en) | Method and pharmaceutical composition for prevention and treatment of brain damage | |
EP0975654A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTIONS | |
BR9708864A (pt) | Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero | |
BR9106377A (pt) | Composicao e processo para o tratamento topico de tecido lesado ou enfermo | |
BR9510015A (pt) | Composto composição farmacéutica e processo para o tratamento de doenças enfecciosas em terapia humana ou veterinária | |
ZA9510108B (en) | Composition and method for prevention and treatment of HIV-1 infection | |
LV12172A (lv) | Kompozicija organu kriokonservesanai um virusu un bakterialas infekcijas arstesanai | |
IL116925A (en) | Combinations of compounds useful for treating HIV infections and pharmaceutical compositions comprising these combinations | |
GB2343844B (en) | Composition and method for treatment of hypertrophic skin accumlations and their prevention | |
AU3607597A (en) | Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases | |
FI965114A0 (fi) | Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä | |
BR9504119A (pt) | Composto composiçao farmacêutica métodos para tratar uma infecçao bacteriana e uma infecçao micoplásmica | |
GB0127618D0 (en) | "Composition and method for treatment of wounds" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |